CSIMarket
 
Establishment Labs Holdings Inc   (NASDAQ: ESTA)
Other Ticker:  
 
 
Price: $43.8600 $-0.09 -0.205%
Day's High: $44.33 Week Perf: -3.71 %
Day's Low: $ 42.79 30 Day Perf: 1.79 %
Volume (M): 68 52 Wk High: $ 60.12
Volume (M$): $ 2,986 52 Wk Avg: $43.31
Open: $44.14 52 Wk Low: $22.05



 Market Capitalization (Millions $) 1,239
 Shares Outstanding (Millions) 28
 Employees 400
 Revenues (TTM) (Millions $) 152
 Net Income (TTM) (Millions $) -71
 Cash Flow (TTM) (Millions $) -12
 Capital Exp. (TTM) (Millions $) 18

Establishment Labs Holdings Inc
Establishment Labs Holdings Inc is a medical technology company that designs, develops, manufactures, and markets breast implants and other medical devices.
The company, which is headquartered in Costa Rica, was founded in 2004 and went public on the NASDAQ stock exchange in 2018.
The company's main product is the Motiva Implant Matrix, a silicone breast implant that is designed to be more natural-looking and feel more like real breast tissue than traditional implants.
The Motiva Implant Matrix uses a proprietary silicone gel formula and a micro-textured surface to create a breast implant that is both safe and aesthetically pleasing.
In addition to its breast implants, Establishment Labs also offers a range of other medical devices, including tissue expanders, surgical instruments, and other surgical solutions.
The company has a global presence, with sales and distribution operations in over 50 countries worldwide.
It has manufacturing facilities in Costa Rica and is also expanding its manufacturing capabilities to other regions, including Europe and the United States.
Overall, Establishment Labs is an innovative medical technology company that is focused on developing and manufacturing safe and effective medical devices for the global market.
Its primary focus on breast implants is unique in the medical device industry and has helped the company carve out a niche in this growing market.


   Company Address: Building B15 and 25 Alajuela 0
   Company Phone Number: 34 2400   Stock Exchange / Ticker: NASDAQ ESTA


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ANIK        3.14% 
BDX        0.76% 
BSX   -1.93%    
CUTR   -1.93%    
MDXG   -1.93%    
OSUR   -1.93%    
• View Complete Report
   



Business Update

Establishment Labs Enhances Breast Aesthetics with Groundbreaking FDA Approvals and Promising Mia Femtech Clini...

Published Thu, Oct 31 2024 1:36 PM UTC

In an era where women s health and wellness have become focal points in medical innovation, Establishment Labs Holdings Inc. continues to make significant strides in the domain of breast aesthetics and reconstruction. The company recently garnered attention at the 9th Annual World Symposium on Ergonomic Implants (WSEI) held in Barcelona, Spain, where it unveiled three-year c...

Business Update

Establishment Labs Releases 2024 Post Market Surveillance Report Amid Expanding U.S. Presence

Published Tue, Oct 15 2024 2:36 PM UTC

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a pioneering medical technology firm dedicated to enhancing women?s health and wellness, particularly in the realms of breast aesthetics and reconstruction, has recently published its 2024 Post Market Surveillance (PMS) Report. This announcement comes as the company moves into a significant growth phase, with broad shipping of...

Business Update

Revolutionary Leap in Breast Augmentation First U.S. Patients Receive Motiva Implants Following FDA Approval

Published Wed, Oct 2 2024 12:47 PM UTC

In a remarkable milestone for women?s health and aesthetics, Establishment Labs Holdings Inc. (NASDAQ: ESTA) has announced that the first U.S. patients have successfully received breast augmentations using the newly FDA-approved Motiva Implants. This significant achievement brings cutting-edge technology to the forefront of cosmetic and reconstructive procedures, marking a n...

Business Update

Establishment Labs Achieves Milestone U.S. FDA Approval for Revolutionary Motiva Breast Implants, Transforming Women...

Published Fri, Sep 27 2024 12:47 AM UTC

In a significant leap forward for breast aesthetics, Establishment Labs Holdings Inc. (NASDAQ: ESTA) has garnered approval from the U.S. Food and Drug Administration (FDA) for its innovative product line featuring Motiva SmoothSilk Ergonomix and Motiva SmoothSilk Round breast implants. This landmark decision represents not only a milestone for the company but also a transfor...

Business Update

Empowering Transformation Establishment Labs? Motiva Implants Redefine Breast Aesthetics in the US,

Published Thu, Sep 26 2024 9:47 PM UTC

Revolutionizing Breast Aesthetics: Establishment Labs FDA Approval Marks a New Era for Women s Health In an invigorating shift for the world of breast aesthetics and reconstruction, Establishment Labs Holdings Inc., a trailblazer in medical technology, has secured the coveted approval from the U.S. Food and Drug Administration (FDA) for its innovative Motiva SmoothSilk Ergo...







Establishment Labs Holdings Inc's Segments
EMEA Europe Middle East Africa    49.26 % of total Revenue
Latin America    24.1 % of total Revenue
Asia-Pacific    27.12 % of total Revenue
North America    0.8 % of total Revenue

  Establishment Labs Holdings Inc Outlook

On February 28 2024 the Establishment Labs Holdings Inc provided following guidance

Establishment Labs Holdings Inc., a leading global medical technology company specializing in women's health and wellness, particularly in the areas of breast aesthetics and reconstruction, has released its financial results for the fourth quarter and full year of 2023. In addition, the company has provided guidance for the year 2024.

The company reported a strong performance in the fourth quarter of 2023, with revenue exceeding expectations. For the full year of 2023, Establishment Labs Holdings Inc. reported a significant increase in revenue compared to the previous year.

Looking ahead to 2024, the company has provided guidance with revenue expected to range between $174 million and $184 mill...





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com